These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 11941942)
1. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp. Nakama H; Fukazawa K Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942 [TBL] [Abstract][Full Text] [Related]
2. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding. Nakama H; Kayano T; Katsuura T; Kamigaito T; Shimada S; Nishikawa N; Yoshii S; Kamijo N Hepatogastroenterology; 1999; 46(27):1730-2. PubMed ID: 10430332 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps. Nakama H; Fattah A; Zhang B; Uehara Y; Wang C Hepatogastroenterology; 2000; 47(32):386-9. PubMed ID: 10791196 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of immunochemical fecal occult blood test for small colorectal neoplasms. Abdul Fattah AS; Nakama H; Zhang B; Uehara Y; Kamijo N; Fujimori K Eur J Med Res; 1997 May; 2(5):227-30. PubMed ID: 9153349 [TBL] [Abstract][Full Text] [Related]
5. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer? Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281 [TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test. Abdul Fattah AS; Nakama H; Kamijo N Eur J Med Res; 1997 Aug; 2(8):361-4. PubMed ID: 9262491 [TBL] [Abstract][Full Text] [Related]
7. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Worthley DL; Smith A; Bampton PA; Cole SR; Young GP Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514 [TBL] [Abstract][Full Text] [Related]
9. Colonoscopic screening of asymptomatic first-degree relatives of colorectal cancer patients. Croitoru L; Trifan A; Maxim MR; Girleanu I; Hulub A; Dimache M; Stanciu C Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):683-6. PubMed ID: 21235115 [TBL] [Abstract][Full Text] [Related]
10. Risk factors in asymptomatic subjects screened for colorectal cancer. Griffiths EK; Shapira DV Cancer Detect Prev; 1990; 14(6):647-50. PubMed ID: 2257563 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening. Zhang B; Fattah A; Nakama H Hepatogastroenterology; 2000; 47(32):414-8. PubMed ID: 10791202 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases. Nishida H; Urano S Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345 [TBL] [Abstract][Full Text] [Related]
13. [Colonoscopic screening of asymptomatic individuals with a family history of colorectal cancer]. Maxim M; Trifan A; Stanciu C Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):993-7. PubMed ID: 21500448 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of immunological fecal occult blood testing for colorectal cancer screening. Nakama H; Kamijo N Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851 [TBL] [Abstract][Full Text] [Related]
15. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797 [TBL] [Abstract][Full Text] [Related]
16. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667 [TBL] [Abstract][Full Text] [Related]
17. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests. McGarrity TJ; Long PA; Peiffer LP Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678 [TBL] [Abstract][Full Text] [Related]
18. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Lage P; Cravo M; Sousa R; Chaves P; Salazar M; Fonseca R; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo P; Nobre-Leitão C Am J Gastroenterol; 2004 Sep; 99(9):1779-84. PubMed ID: 15330918 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Yamamoto M; Nakama H Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199 [TBL] [Abstract][Full Text] [Related]
20. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]